Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer
- PMID: 27354998
- PMCID: PMC4908458
- DOI: 10.1016/j.gore.2016.05.006
Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer
Abstract
Ovarian cancer is commonly diagnosed at an advanced stage, with disease involving the upper abdomen. The finding of enlarged cardiophrenic lymph nodes (CPLNs) on pre-operative imaging often indicates the presence of malignant spread to the mediastinum. Surgical resection of CPLN through a transdiaphragmatic approach can help to achieve cytoreduction to no gross residual. A retrospective chart review was conducted on all patients who underwent transdiaphragmatic cardiophrenic lymph node resection from 8/1/11 through 2/1/15. All relevant pre-, intra-, and post-operative characteristics and findings were recorded. A brief description of the surgical technique is included for reference. Eleven patients were identified who had undergone transdiaphragmatic resection of cardiophrenic lymph nodes. Malignancy was identified in 18/21 (86%) of total lymph nodes submitted. The median number of post-operative days was 7. The overall post-operative morbidity associated with CPLN resection was low, with the most common finding being a small pleural effusion present on chest x-ray between POD# 3-5 (55%). Transdiaphragmatic CPLN resection is a feasible procedure with relatively minor short-term post-operative morbidities that can be used to achieve cytoreduction to no gross residual disease.
Keywords: Cardiophrenic lymph nodes; Cytoreductive surgery; Diaphragm resection; Ovarian cancer; Post-operative morbidity.
Figures
References
-
- Aletti G.D., Dowdy S.C., Gostout B.S. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet. Gynecol. 2006;107(1):77–85. - PubMed
-
- Aletti G.D., Long H.J., Podratz K.C., Cliby W.A. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Gynecol. Oncol. 2007;104(1):212–216. - PubMed
-
- American Cancer Society, Inc. Cancer Facts & Figures 2015. Available at: www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-04... (Accessed on: May 25, 2015).
-
- Bashir S., Gerardi M.A., Giuntoli R.L., 2nd, Montes T.P., Bristow R.E. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer. Gynecol. Oncol. 2010;119(2):255–258. - PubMed
-
- Benedetti Panici P., Di Donato V., Fischetti M. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: analysis and management of complications in upper abdominal surgery. Gynecol. Oncol. 2015;137(3):406–411. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources